Jerzy Bełtowski Selected Research

Aldosterone

1/2021

Salt Intake, Aldosterone Secretion, and Obesity: Role in the Pathogenesis of Resistant Hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jerzy Bełtowski Research Topics

Disease

24	Hypertension (High Blood Pressure) 11/2023 - 01/2003
22	Obesity 01/2022 - 06/2002
13	Atherosclerosis 01/2019 - 03/2002
11	Insulin Resistance 01/2022 - 02/2003
8	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 03/2008
4	Type 2 Diabetes Mellitus (MODY) 09/2018 - 02/2003
4	Hypertrophy 09/2018 - 01/2003
4	Neoplasms (Cancer) 09/2018 - 12/2007
3	Hyperhomocysteinemia 01/2020 - 07/2004
3	Heart Failure 09/2018 - 06/2006
3	Diabetes Mellitus 01/2018 - 06/2006
3	Fatty Liver 01/2017 - 12/2007
3	Dyslipidemias (Dyslipidemia) 01/2017 - 01/2008
3	Hyperlipidemias (Hyperlipidemia) 01/2017 - 06/2006
3	Hyperinsulinism (Hyperinsulinemia) 11/2013 - 06/2006
3	Cardiovascular Diseases (Cardiovascular Disease) 07/2012 - 03/2004
3	Hypoxia (Hypoxemia) 08/2010 - 03/2004
3	Myocardial Ischemia (Ischemic Heart Diseases) 03/2008 - 02/2003
2	Fibrosis (Cirrhosis) 10/2019 - 09/2018
2	Diabetic Angiopathies (Diabetic Angiopathy) 01/2019 - 01/2017
2	Inflammation (Inflammations) 01/2018 - 03/2004
2	Body Weight (Weight, Body) 02/2010 - 03/2004
2	Essential Hypertension 03/2008 - 05/2006
1	Renovascular Hypertension (Goldblatt Syndrome) 01/2023
1	Chronic Progressive Multiple Sclerosis 01/2020
1	Multiple Sclerosis 01/2020
1	Disease Progression 01/2020
1	Weight Loss (Weight Reduction) 05/2019
1	Endometrial Neoplasms (Endometrial Cancer) 09/2018
1	Non-alcoholic Fatty Liver Disease 01/2017
1	Osteoporosis 11/2016
1	Diabetes Complications 10/2016
1	Vascular Remodeling 01/2014
1	Edema (Dropsy) 01/2013
1	Reperfusion Injury 07/2012

Drug/Important Bio-Agent (IBA)

21	LeptinIBA 01/2014 - 06/2002
6	EnzymesIBA 01/2023 - 01/2004
6	Proteins (Proteins, Gene)FDA Link 01/2020 - 02/2003
6	AntioxidantsIBA 01/2020 - 01/2002
6	Insulin (Novolin)FDA Link 09/2018 - 06/2006
6	Nitric Oxide (Nitrogen Monoxide)FDA Link 09/2018 - 12/2003
5	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2023 - 08/2010
5	SodiumIBA 01/2014 - 03/2004
5	Hormones (Hormone)IBA 02/2012 - 06/2006
5	Fatty Acids (Saturated Fatty Acids)IBA 12/2011 - 02/2003
5	Adenosine Triphosphatases (ATPase)IBA 02/2010 - 06/2002
4	HomocysteineIBA 01/2020 - 07/2004
4	Aryldialkylphosphatase (Paraoxonase)IBA 09/2018 - 01/2002
4	AdipokinesIBA 01/2018 - 06/2006
4	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 02/2003
4	endothelium-dependent hyperpolarization factor (EDHF)IBA 01/2014 - 05/2006
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2012 - 03/2002
3	Nitric Oxide Synthase (NO Synthase)IBA 01/2023 - 07/2004
3	CholesterolIBA 01/2010 - 03/2002
3	Triglycerides (Triacylglycerol)IBA 01/2008 - 02/2003
3	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2007 - 10/2003
2	SaltsIBA 11/2023 - 01/2021
2	Glycerol (Glycerine)FDA LinkGeneric 01/2022 - 12/2011
2	Nonesterified Fatty Acids (NEFA)IBA 01/2022 - 12/2011
2	Metformin (Glucophage)FDA LinkGeneric 09/2018 - 10/2016
2	homocysteine thiolactoneIBA 09/2018 - 11/2016
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2014 - 02/2008
2	Rosiglitazone (Avandia)FDA Link 11/2013 - 01/2013
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2013 - 01/2003
2	ResistinIBA 03/2008 - 02/2003
2	Lipoproteins (Lipoprotein)IBA 03/2008 - 10/2002
2	AdiponectinIBA 03/2008 - 02/2003
2	Transcription Factors (Transcription Factor)IBA 01/2008 - 12/2007
2	Ouabain (G Strophanthin)IBA 04/2007 - 01/2004
2	sodium-translocating ATPase (ATPase, sodium)IBA 04/2007 - 01/2004
2	AcidsIBA 01/2004 - 10/2003
1	CystathionineIBA 01/2023
1	LyasesIBA 01/2023
1	Angiotensin IIIBA 01/2023
1	polysulfideIBA 01/2022
1	AldosteroneIBA 01/2021
1	Neuroprotective AgentsIBA 01/2020
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2020
1	Cladribine FDA LinkGeneric 01/2020
1	Biomarkers (Surrogate Marker)IBA 10/2019
1	Exenatide (Byetta)FDA Link 05/2019
1	Hypoglycemic Agents (Hypoglycemics)IBA 09/2018
1	Advanced Glycation End ProductsIBA 09/2018
1	ProgranulinsIBA 01/2017
1	HDL LipoproteinsIBA 11/2016
1	Bone Density Conservation AgentsIBA 11/2016
1	EsterasesIBA 11/2016
1	Diphosphonates (Bisphosphonates)IBA 11/2016
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2014
1	EndocannabinoidsIBA 11/2013
1	ThiazolidinedionesIBA 01/2013
1	Pioglitazone (Actos)FDA Link 01/2013
1	Pravastatin (Pravachol)FDA LinkGeneric 12/2011
1	Cholecalciferol (Vitamin D3)FDA Link 12/2011
1	Vitamin D FDA LinkGeneric 12/2011
1	Atorvastatin (Lipitor)FDA Link 12/2011
1	Paraoxon (E600)IBA 07/2010

Therapy/Procedure

2	Therapeutics 01/2019 - 04/2008
1	Surgical Instruments (Clip) 01/2023
1	Highly Active Antiretroviral Therapy (HAART) 11/2016